Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Alphamab Oncology

Biotech & Life Sciences · Suzhou Shi, China · Founded 2009 · IPO 2019 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.08B
Market cap · Apr/2026
Revenue
$88M
Latest reported FY

Investors

8 investors on Alphamab Oncology's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 6 investors entered at this stage
Advantech Capital
OrbiMed
Janchor Partners
PAG
China Ventures Fund
Heritage Provider Network
Series B+ 2 investors entered at this stage
Adrian Cheng
Hudson Bay Capital Management

Global footprint

Where Alphamab Oncology has talent and traffic

Web traffic by country
2.9K monthly visits
across markets
🇺🇸 United States65.5%
🇯🇵 Japan20.7%
🇮🇳 India6.9%
🇭🇰 Hong Kong6.9%
Top 4 markets shown

See Alphamab Oncology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo